Exploring the social responsibility of business: Final Danforth Lecture features former head of Merck
Vagelos will explore these examples in detail for his talk on “The Social Responsibility of Business” to be held at 4 p.m. Monday, November 13, in Graham Chapel. The program will also feature a panel discussion featuring Washington University-associated business experts. It is the final installment of the Danforth Lecture Series.
Female M.B.A. students aim to increase their numbers in b-school and the workplace
WHAT: The Olin School of Business at Washington University in St. Louis is hosting the National Association of Women M.B.A.’s conference and job fair. More than 800 women from all over the country are expected to attend. WHEN: Nov. 3-5, 2006. Starting at 8 a.m. WHERE: The Knight Center and Simon Hall at Washington University, […]
WUSTL-Fudan Executive M.B.A. ranked No. 1 in China, No. 8 in world
The Financial Times has, for the first time, ranked the Executive M.B.A. program, a joint venture between the Olin School of Business at Washington University in St. Louis and Shanghai-based Fudan University’s School of Management.
Renowned legal scholar to discuss antitrust
The Law School’s Public Interest Law and Policy Speakers Series, in conjunction with the Federalist Society and the Assembly Series, will present Richard Epstein at 3 p.m. Tuesday, October 31, in the Anheuser Busch Moot Courtroom (Room 310). The lecture is free and open to the public.
The well-known libertarian and influential legal scholar will discuss the question, “Has Modern Complex Litigation Outgrown the Federal Rules of Civil Procedures? The Case of Antitrust.”
Legal scholar, culture critic to speak for Assembly Series
Richard Epstein and bell hooks will speak Oct. 31 and Nov. 1, respectively.
Female M.B.A. students aim to increase their numbers in b-school and the workplace
Medical and law schools have seen the percentage of women enrolled grow steadily over the past 20 years, to the point that women frequently represent at least half of most classes. Business schools have yet to catch up with this trend but the Olin School of Business is pioneering the way for women to increase their numbers in MBA programs. More than 800 people are expected to attend the National Association of Women MBA’s annual conference and career fair in early November at WUSTL. This event comes after Olin’s admission to the Forte Foundation, a consortium dedicated to promoting women in business.
Business faculty to deliver insights at Thought Leadership conference
Aimed at executives, senior and mid-level managers and human-resource directors, the conference takes place Oct. 26.
Understanding choices adult children make to care for elderly parents should help policymakers
According to a 2005 U.S. Department of Health and Human Services report, nursing homes in the United States in 1999 cost an average of $47,000 per year, with costs rising each year. Choosing a course of care for an elderly family member is both a financial decision and an emotional one. A business and economics professor at Washington University in St. Louis is using game theory to understand these long-term care decisions. More…
Business innovation is not dependent on creative people
American companies continue to grapple with staying competitive in the global economy. Increasingly, companies and business gurus are citing innovation as the key to sustaining American business’ strength. What’s not clear is what it means for a company to be innovative. Washington University business professors say the best way to infuse innovation into a company is not by hiring creative people, but by managing innovation in a systematic way. More…
Pharmaceutical industry wastes $50 billion a year due to inefficient manufacturing
The pharmaceutical industry could be wasting more than $50 billion a year in manufacturing costs alone, costs that could translate in to lower prices or greater research and development – according to findings of the largest empirical study ever performed of pharmaceutical manufacturing and the Food and Drug Administration monitoring policies. More…
Older Stories